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SUMMARY
Neutrophils are short-lived blood cells that play a
critical role in host defense against infections. To
better comprehend neutrophil functions and their
regulation, we provide a complete epigenetic over-
view, assessing important functional features of their
differentiation stages from bone marrow-residing
progenitors to mature circulating cells. Integration
of chromatin modifications, methylation, and tran-
scriptome dynamics reveals an enforced regulation
of differentiation, for cellular functions such as
release of proteases, respiratory burst, cell cycle
regulation, and apoptosis. We observe an early
establishment of the cytotoxic capability, while the
signaling components that activate these antimicro-
bial mechanisms are transcribed at later stages,
outside the bone marrow, thus preventing toxic ef-
fects in the bone marrow niche. Altogether, these
data reveal how the developmental dynamics of the
chromatin landscape orchestrate the daily produc-
tion of a large number of neutrophils required for
innate host defense and provide a comprehensive
overview of differentiating human neutrophils.
INTRODUCTION
Human neutrophils, with a daily production rate of 1011 cells
(Strydom and Rankin, 2013), are the most abundant type of
leukocytes and an essential element of the innate immune
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system. Patients with either acquired or inherited defects in
neutrophil development, migration, or function show enhanced
susceptibility to infection by opportunistic pathogens (Erlacher
and Strahm, 2015; Fodil et al., 2016). Neutrophils have a variety
of effector functions, such as phagocytosis of pathogens (Nau-
seef and Borregaard, 2014), intracellular killing in phagosomes
with reactive oxygen species (ROS), and antimicrobial granule
components (Darrah and Andrade, 2013; Garcia-Romo et al.,
2011; Hakkim et al., 2010). They are produced in the bone
marrow and reach the bloodstream across five main stages of
differentiation. Myeloblasts (MBs) undergo 1 week of prolifera-
tion, followed by maturation (Bainton et al., 1971), then progres-
sively move through promyelocytes and myelocytes (P/Ms),
metamyelocytes (MMs), band neutrophils (BNs), and finally
segmented neutrophils (SNs). During this time they produce
different granules filled with antimicrobial compounds and
develop the abilities of respiratory burst and chemotaxis. SNs
represent a reserve pool fromwhich cells are constantly released
into the peripheral bloodstream, as non-dividing polymorphonu-
clear neutrophils (PMNs). The differentiation process exhibits a
precise and tightly defined transcriptional program (Theilgaard-
Mo¨nch et al., 2005). In this study, we used total RNA sequencing
(RNA-seq) to characterize and compare gene expression pro-
files of the various differentiation stages. Histone modifications,
chromatin immunoprecipitation sequencing (ChIP-seq), and
whole-genome bisulfite sequencing (WGBS) have been used to
describe the epigenetic landscapes underlying these coordi-
nated changes. For each stage we defined DNAmethylation pat-
terns and characterized four active histone marks—H3 lysine-4
trimethylation (H3K4me3), H3 lysine-27 acetylation (H3K27ac),
H3 lysine-4 monomethylation (H3K4me1), H3 lysine-36 trimethy-
lation (H3K36me3)—and two repressive marks—histone H3
lysine-9 trimethylation (H3K9me3) and histone H3 lysine-27
trimethylation (H3K27me3). The integration of these analyses
reveals a high degree of coordination between the dynamics of
histone modifications and transcriptional changes. The activa-
tion of PMNs triggers the host defense. This process is accom-
plished through some functional key responses as respiratory
burst, cell migration, and degranulation. Integrating our func-
tional assays with the epigenomic analysis gave us the opportu-
nity to further characterize the timing of these important
processes.
RESULTS
Transcriptional Changes in Neutrophil Development
To better understand neutrophil functions and their regulation,
we analyzed the transcriptomes of circulating neutrophils and
their progenitor populations (Figure S1A). Our analysis revealed
quantitative and qualitative differences in expression among
PMNs, SNs, and the other differentiation stages. We used cumu-
lative distribution of expression to explore the complexity of the
transcriptome (Mele´ et al., 2015) and found that in PMNs and
SNs, the genes with higher expression give a smaller contribu-
tion to the global transcriptional output than in other stages
(Figure 1A). To deepen the transcriptome comparisons, we per-
formed differential gene expression analysis between subse-
quent stages and between the initial and the final stage (Fig-
ure 1B; Table S1). Downregulated genes in the P/M-PMNs
comparison enriched Gene Ontology (GO) categories related
to cell functions, such as metabolism, translation, cell cycle,
DNA replication, mitochondria, and cell divisions (Figures S1B
and S1C). On the other hand, the upregulated genes enriched
fewer categories, related mainly to immune system functions
and vesicle transport processes (Figures S1B and S1C). The
analysis of differentially expressed transcripts across all stages
found 108 genes with significant changes in transcription start-
ing site (TSS) use (Table S1). Only for 12 genes did this lead to
changes in the open reading frame (Table S1). Cluster analysis
and gap statistic (Tibshirani et al., 2001) summarized the differ-
entially expressed genes in at least one of the five comparisons
(P/M-MM, MM-BN, BN-SN, SN-PMN, or P/M-PMN) in seven
main clusters (r1–r7; Figure 1C; Table S1). Genes in clusters
r1 and r2 showed an increase in expression toward the latter
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Figure 1. Transcriptome and Epigenome Dynamics of Neutrophil Differentiation
(A) Cumulative distribution of the average fraction of total transcription contributed by protein-coding genes when sorted from most to least expressed in each
differentiation stage.
(B) Top: bar plots reporting differentially expressed genes (posterior probability > 0.5 and absolute fold change > 2) in the comparisons P/M-MM,MM-BN, BN-SN,
and SN-PMN. Bottom: May-Gr€unwald-Giemsa staining of the isolated cells.
(C) Heatmap displaying the expression patterns of the clusters (r1–r7) identified by the K-means analysis of the genes differentially expressed in at least one
comparison.
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stages of differentiation and enriched GO terms related to
immune system and signal transduction (Table S1). Genes in
clusters r5, r6, and r7 displayed a decreasing expression trend
with differentiation progression and enriched GO terms related
to translation, mitochondria, and cell cycle (Table S1). The
remaining two clusters (r3 and r4) were made by genes whose
expression increased during the intermediate stages of differen-
tiation and then decreased at the PMN stage. These enriched
GO terms related to vesicle transport and signal transduction
(Table S1).
Epigenetic Dynamics in Neutrophil Development
In order to define the chromatin dynamics underlying the
changes in gene expression during neutrophil differentiation,
we determined the epigenetic landscape in the five differentia-
tion stages and integrated them with the results of the transcrip-
tome characterization. Principal-component analysis (PCA) of
the four active histone modifications (H3K4me3, H3K27ac,
H3K4me1, and H3K36me3) revealed a good separation among
the five neutrophil development stages (Figure S2A). In contrast,
PCA for the two repressivemarks (H3K9me3 and H3K27me3) re-
vealed donor-specific, rather than stage-specific, clusters (Fig-
ure S2A). Moreover, PCA analysis of DNA methylation profiles
did not reveal differences among the five differentiation stages
(Figure S2B), and only a few differentially methylated regions
(DMRs) were identified between subsequent stages of differen-
tiation (Figure S2C; Table S2). Altogether, histone mark and
DNA methylation results indicate a modest contribution of
repressive epigenetic mechanisms in the described phases of
neutrophil differentiation.
The six different histone modifications were also used to
perform a genome segmentation analysis (Ernst and Kellis,
2012), which indicated 12 representative states (Figure S3A).
These were collapsed into a smaller set for ease of interpretation
(Carrillo-de-Santa-Pau et al., 2017) to obtain four main cate-
gories: active, enhancer, low signal, and repressed (Figure S3A).
We then focused on the changes of chromatin states, identifying
between 15,685 and 27,604 at each consecutive differentiation
transition (Figure 2A; Table S3). In agreement with the differential
gene expression analysis results, the consecutive transitions
with most changes were P/M to MM and SN to PMN. Upregu-
lated genes were enriched in changes toward active states
(i.e., from low signal/repressed to active/enhancer), while down-
regulated genes were enriched in transitions toward inactive
states (i.e., from active/enhancer to low signal/repressed) in
the majority of differentiation stages (Figure S3B). H3K27ac,
strongly associated with active and enhancer states, is among
the most highly informative marks about gene regulation (Karlic
et al., 2010; Rada-Iglesias et al., 2011). For this reason, we
decided to focus our attention on the 9,100 genomic regions
characterized by changes in H3K27ac levels during differentia-
tion (see Experimental Procedures). Using co-occupancy with
H3K4me3 to identify promoter regions and co-occupancy with
H3K4me1 to identify enhancers, in addition to a supervised clus-
ter of the H3K27ac log ratio RPKM (reads per kilobase of tran-
script per million mapped reads), we divided these regions in
two categories each made of eight subgroups (Figure 2B; Table
S4). The intersection of these regions with the chromatin states
revealed an overlap with active (promoter) regions in the
H3K4me3-enriched clusters and an overlap with enhancers in
the H3K4me1-enriched clusters (Figure S3C), corroborating
our partitioning. We refer to the clusters as promoter (p1–p8)
and enhancer (e1–e8). In both promoter and enhancer clusters
about two-thirds of dynamic regions displayed an increase in
H3K27ac (i.e., increase in activity), while about one-third dis-
played a reduction in H3K27ac (i.e., reduction in activity). The
contingency tables made by the intersection of the genes in
the RNA-seq clusters gave significant Pearson’s chi-square sta-
tistics for both acetylation clusters (enhancer chi-square = 513,
p = 0.0005; promoter chi-square = 1,364, p = 0.0005). We tested
the association of each gene expression cluster with each dy-
namic acetylation cluster (Figures 2C and 2D). Interestingly we
found that expression clusters r1 and r2, containing genes with
increased expression, were significantly associated with pro-
moter clusters p1 and p2 and enhancer clusters e1 and e2.
Expression clusters r6 and r7, formed by genes with decreased
expression, were significantly associated with promoter clusters
p5 and p6 and enhancer clusters e5 and e6, all characterized by
reduced histone acetylation levels. The expression cluster r4
included genes with an increased expression in the PM-to-MM
transition, and the same trend was observed in the associated
acetylation clusters e4 and p4.
Dynamically acetylated enhancers of the same cluster had a
genomic distance closer than expected by chance (permutation
test Z = 21). This observation prompted us to investigate the
presence of super-enhancers (SEs), regulatory elements made
by clusters of enhancer that specify cell identity (Whyte et al.,
2013; Witte et al., 2015). We made use of the established
ROSE algorithm to identify 629 SEs, which could be clustered
in three main groups (Figure 3A; Table S4). SE cluster 1 (SE1)
was made by elements more acetylated in the P/M state,
showing a decreasing trend of acetylation in the subsequent
stages of differentiation; SE cluster 2 (SE2) had an opposite
trend, with acetylation increasing in the first stages and then
decreasing at the SN-PMN transition. Finally, SE cluster
3 (SE3) contained SEs activated at the end of differentiation pro-
cess. Genes controlled by SEs belonging to cluster 3 were the
only ones showing an enrichment for functional categories, all
of them related to PMN’s activation (Figures 3B and 3C).
Transcription Factors and Release from Bone Marrow
Transcription factors (TFs) bind regulatory elements (promoters
and enhancers) and enforce transcriptional programs (Lambert
et al., 2018; White et al., 2013). To identify the TFs that have an
important role in granulopoiesis, we searched for TF family
consensus binding sites, enriched in regions with increased
acetylation (clusters p1–p4 and e1–e4) compared with regions
with decreased acetylation (clusters p5–p8 and e5–e8) and
vice versa. We found enrichments for basic leucine zippers
(bZIP), SOX, zinc fingers (ZF), nuclear receptors (NR), basic
helix-loop-helices (bHLH), NF-kB family members (REL), home-
odomains, and ETS families, with stronger signal in regions with
increased acetylation (Figure 4A). Regions with decreased
H3K27ac signal showed enrichment for MYB- and GATA-bind-
ing motifs. We integrated these results with gene expression
analysis results and identified for each enriched motif TF genes
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differentially expressed in at least one of the comparisons
between differentiation stages (Figure 4B). The majority of these
TFs (81 of 95) were differentially expressed in only one of the four
comparisons. Twelve of the remaining 14 genes, differentially
expressed at multiple transitions, were always either up- or
downregulated. Only 2 genes, differentially expressed atmultiple
transitions, had a trend inversion: TGIF2 was downregulated in
the P/M-MM transition and upregulated in the BN-SN transition,
and ETS1 was upregulated in the P/M-MM transition and down-
regulated in the SN-PMN transition.
The P/M-to-MM transition included the majority (65 of 95) of
differentially expressed TFs, followed by the bone marrow-to-
blood transition (SN to PMN) with 20 differentially expressed
TFs (Figure 4B). Interestingly 19 of them were downregulated,
and NKX3-1, the only upregulated one, had a reported transcrip-
tional repressor activity (Simmons and Horowitz, 2006). The TF
families MYB, GATA, and E2F were exclusively overrepresented
in enhancers and promoters with decreased acetylation, reflect-
ing their role in other lineages and cell cycle progression
(Bartunek et al., 2003; Ghazaryan et al., 2014). Accordingly,
differentially expressed genes from these families were all down-
regulated (Figure 4B).
Acquisition and Control of Cytotoxic Capabilities
Cell proliferation is halted during neutrophil differentiation; our
transcriptome and epigenome data indicated that this occurs
in the bone marrow, as previously reported (Klausen et al.,
2004; Theilgaard-Mo¨nch et al., 2005). Flow cytometry quantifica-
tion of Ki67, a marker for proliferation (Gerdes, 1990), showed
that the majority of the signal drops in the early stages of myeloid
-log10(Pval)
4506
1859
2242
18642
8573
9181
8319
1176
8604
4892
3663
3490
2559
5192
2873
10025
MM MMP/M BN
3887
4458
4079
7664
3917
7511
2879
5781
2627
14182
4067
16798
18489
6207
8269
4709
BN SN SN PMN
Enhancer
Low signal
Repressed
r1
r2
r3
r4
r5
r6
r7
p1    p2     p3      p4     p5     p6      p7      p8
e1    e2     e3      e4     e5     e6      e7      e8
10
20
30
40
50
60
r1
r2
r3
r4
r5
r6
r7
4
6
8
10
12
14
16
-log10(Pval)
A                                                        
B                                                        C                                                        
                                                                 D                                                           
P
ro
m
ot
er
En
ha
nc
er
H3K4me3 H3K4me1H3K27ac
P
/M
p1
p2
p3
p4
p5
p7p6p8
e1
e2
e5
e7
e6
M
M
B
N
S
N
P
M
N
e3
e4
e8
P
/M
M
M
B
N
S
N
P
M
N
P
/M
M
M
B
N
S
N
P
M
N
M
M
B
N
Æ
B
N
S
N
Æ
S
N
P
M
N
Æ
P
/M
M
M
Æ
-1.0
0
1.0
Figure 2. H3K27 Acetylation Drives Consecutive Neutrophil Differentiation Stages
(A) Sankey diagrams of consistent chromatin states for each of the neutrophil differentiation transitions. Different chromatin states are represented with specific
color codes: green indicates active regions, purple enhancers, amber low signal regions, and dark blue heterochromatic regions. The red connecting lines
indicate transitions toward inactive states (low signal and repressed); the light blue lines indicate transitions toward active states (active and enhancer).
(B) Left: stacking heatmaps of H3K27ac (yellow), H3K4me3 (red), and H3K4me1 (orange) ChIP-seq of promoters and enhancers (±5 kb) with dynamic acetylation
during different stages of neutrophil differentiation. Right: differentially acetylated promoter and enhancer during two consecutive neutrophil progenitor stage
transitions are clustered as acetylation clusters for promoters p1–p8 and for enhancers e1–e8, respectively. Acetylation gains are presented in red and acetylation
losses in green.
(C andD) Heatmaps representing the association between the expression clusters identified in Figure 1C and the promoter (C) and enhancer (D) clusters identified
in Figure 2B. Only significant corrected p values (<0.05) are reported in the figures.
Cell Reports 24, 2784–2794, September 4, 2018 2787
differentiation (P/M-to-MM transition) and a complete loss is
observed at the SN stage (Figure 5A). Neutrophils are phago-
cytes, capable of ingesting and killing microorganisms by the
release of ROS, highly toxic chemical species, potentially harm-
ful for the bonemarrow niche. Themulticomponent nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase complex,
consists of a membrane-associated heterodimer cytochrome
b558 and a trio of cytosolic proteins (Nauseef and Borregaard,
2014). This complex confers the unique neutrophils’ ability to
generate a family of reactive oxidizing agents (Weiss, 1989),
and we focused on it to characterize the exact dynamic of this
defense mechanism formation. Upon activation, the intact
NADPH oxidase generates superoxide, the precursor to
hydrogen peroxide and other ROS with microbial activity, at
the plasma membrane and at the membranes of phagosomes
where particles are ingested (Figure 5B). The oxidase complex
subunits showed different expression dynamics during differen-
tiation (Figure 5C). CYBA (p22-phox), NCF4 (p40-phox), RAC2,
and RAC1 had stable expression levels, whereas CYBB (gp91-
phox) was maximally expressed between the MM and BN
stages, and the cytoplasmic components NCF1 (p47-phox)
and NCF2 (p67-phox) were upregulated in the P/M-to-MM tran-
sition and then remained stable in the subsequent stages. In
order to verify when the complex is functional, we used an
Amplex Red hydrogen peroxide assay to detect the NADPH
oxidase activity. Stimulation of PAF-primed neutrophils with
the bacterial-derived tripeptide formyl-MLP (PAF/fMLP) (Drew-
niak et al., 2013; Kuijpers et al., 2005) was used to ensure the
maximal stimulation via the natural receptor. At P/M the NAPDH
oxidase activity was very low. It became readily detectable at the
next stage of differentiation (MM), as shown by the activation
with the cell-permeable phorbol ester PMA, which directly acti-
vates intracellular protein kinase C (Moore et al., 1991). In
contrast, stimulation via the cell-impermeable PAF/fMLP re-
vealed a delay in ROS formation, detectable from the BN stage
onward (Figure 5D). In agreement with the increase in transcrip-
tion level and functional activity of NADPH oxidase, we found
that cytochrome b558, the heterodimer of gp91-phox and p22-
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phox, and fMLP-receptor FPR1 levels
(both determined by flow cytometry)
increased during differentiation (Figures
S4A and S4B). Additionally we also noted
that CXCR1, CXCR2, CXCR4, FPR1,
FPR2, PTAFR, and C5AR1, activating G
protein-coupled receptors for the major
chemotactic factors in neutrophils, follow the same expression
trend (Figure S4C), and are all in the expression cluster r1.
Transcriptional and Epigenetic Control of Granule
Proteins
Another main function of the neutrophils is the degranulation
consisting in the release of an assortment of proteins, stored in
different granules. These granules are distinguishable by their
contents: azurophilic granules (AG), specific granules (SG),
gelatinase-containing granules (GG), ficolin-containing granules
(FG), and secretory vesicles (SV) (Rørvig et al., 2013). To gain
insight in the control of the biogenesis of these granules during
differentiation, we examined available proteomic data (Rørvig
et al., 2013) and selected the proteins whose granule assign-
ments were supported by other existing literature (Table S6)
and the granule proteins assigned to the cell membrane (CM)
fraction. We found that genes encoding proteins belonging to
various granules display different expression trends (Figure 6A),
and in agreement with this, they showed a tendency to belong to
different RNA-seq clusters (chi-square = 91.8062, p < 0.0005;
Figure S5A). AG proteins were associated with clusters r6 and
r7 (Fisher’s exact test corrected p < 0.05), while CM proteins
were associated with cluster r1 (Fisher’s exact test corrected
p < 0.005) and SG proteins with cluster r4 (Fisher’s exact test
corrected p = 3.1 3 106).
To determine the time of appearance of AG’s proteolytic capa-
bility, we measured their combined serine protease activity, in
sorted neutrophil progenitors, upon CytoB/fMLP stimulation or
Triton X-100 lysis. The results showed that although AG proteins
have already been produced and stored at P/M stage, the prote-
ase release machinery is not in place before the BN stage. P/M
cells were found to harbor the highest concentration of proteo-
lytic activity, which was then diluted over to the MM daughter
cells and remained stable in activity thereafter (Figure 6B). Genes
of different granule proteins, similarly to what observed for gene
expression, displayed different H3K27ac trends (Figure S5B). In
agreement with this, genes encoding soluble AG proteins, such
as AZU1, PRTN3, and ELANE, had a high level of the H3K27ac in
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the P/M stage and reduced in the MM stage (Figures 6C and
S5B) and were enriched in clusters p5, p6, and e5 (Fisher’s
test corrected p values: for p5, p = 6.64 3 103; for p6,
p = 6.64 3 103; and for e5, p = 3.65 3 102). In contrast, SG-
associated genes, such as LTF, with increased acetylation in
the P/M-to-MM transition, were enriched mainly in clusters p4
and e4 (Fisher’s test corrected p values: for p4, p = 1.7 3
103; and for e4, p = 2.88 3 102) (Figures 6C and S5B). The
SV-associated genes as MMP25 displayed increased acetyla-
tion at the final stages of differentiation (Figures 6C and S5B).
DISCUSSION
Our study dissects human neutrophil differentiation through the
analysis and integration of transcriptomes, epigenomes, and
functional assays of five consecutive stages of maturation.
In the transcriptome of a cell, a relative small number of genes
contribute to a large fraction of the expression (Mele´ et al., 2015).
Interestingly, we found this trend to be less pronounced in the
two latest stages of neutrophil maturation, SN and PMN, indi-
cating a change in transcriptome features at the final stages of
the differentiation.
The P/M-to-MN and SN-to-PMN were the consecutive transi-
tions with the largest numbers of differentially expressed genes
and changes in chromatin states. These transcriptomic and epi-
genomic differences reflect the important differences between
these stages. Indeed, the P/M-to-MN transition denotes a pas-
sage from cells capable of dividing to cells with indented nuclei
and unable to divide (Wahed and Dasgupta, 2015). Similarly,
the SN-to-PMN transition denotes the passage from bone
marrow to the bloodstream.
Different stages of maturation do not display relevant differ-
ences in DNA methylation. This suggests that the unique pat-
terns of DNA methylation found in neutrophils (Schuyler et al.,
2016) are established at earlier stages of differentiation, in agree-
ment with a previous study reporting that themajority of changes
in DNA methylation occur between the oligopotent common
myeloid progenitor and the bipotent granulocyte monocyte pro-
genitor, with only minor changes occurring in the P/M-to-PMN
transition (Ro¨nnerblad et al., 2014). Our study extends this result,
with more differentiation steps during maturation of the granulo-
cyte progenitors, thus providing a more detailed description of
the dynamics of transcriptional enhancers’ commitment. More-
over, the use of WGBS allowed a 60-fold increase of the number
of CpG analyzed residues.
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Figure 4. Transcription Factors with Enriched Binding Sites in Dynamic Acetylated Regions
(A) Transcription factor (TF) family motif enrichment in the dynamic acetylated regions in Figure 2B.
(B) RNA expression in log2(FPKM+1) of the TF family members in (A) differentially expressed in at least one of the comparison between differentiation stages; the
asterisk denotes the transitions where the expression is significantly different.
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In line with the DNAmethylation results the two repressive his-
tone marks analyzed cannot be used to discriminate among
neutrophil differentiation stages. Previous studies demonstrated
that repressive H3K9me3 and H3K27me3 marks and DNA
methylation have a crucial role in cell commitment (Bock et al.,
2012; Hawkins et al., 2010), and our results suggest that in neu-
trophils, they do not play any further roles once lineage commit-
ment is achieved.
We focused our attention on promoter and enhancer regions
subject to dynamic acetylation across differentiation. These re-
gions, subdivided in clusters, showed significant overlaps of
target genes with the clusters of differentially expressed genes,
highlighting a strong correlation between epigenomic and tran-
scriptomic profiles at the various differentiation stages. The
study of dynamically acetylated regions led us to identify SEs
differently modulated across differentiation; a consistent group
of these is activated at the end of differentiation and have as po-
tential targets the genes involved in immunological response and
neutrophil activation.
To further characterize the dynamically acetylated regions, we
looked for enriched TF binding sites and integrated them with
the differential expression results. This approach aimed to high-
light TFs playing a potential role in the differentiation process.
CEBPA is a TF of the bZIP family with amajor role in the neutrophil
differentiation program, and it is known to be crucial for the devel-
opmentofacutemyeloid leukemia (AvellinoandDelwel, 2017).Our
results show that CEBPA is highly expressed in the bone marrow
and then significantly downregulated in the SN-to-PMN transition.
CEBPE, another member of the bZIP family, is also highly
expressed in the bone marrow and is downregulated in the SN-
to-PMN transition but also in the preceding transition, BN to SN.
Interestingly CEBPEmodulates someof the lactoferrin-containing
SG genes (Khanna-Gupta et al., 2007) and regulates the expres-
sionofGGandFGgranule genes (Gombart etal., 2001), bothchar-
acterized by a decreasing trend of expression at the PMN stage.
The transcriptome and epigenome characterizations depicted
a precise differentiation program that, in agreement with previous
findings (Theilgaard-Mo¨nch et al., 2005), progressively activates
immune functionalities, turning off essential cell processes. The
study of five differentiation stages gave us the opportunity to
detect with better resolution where the cell cycle inactivation
takes place. We have shown that the P/M stage is the most pro-
liferative, with Ki67 signal dimming in the following MM and BN
stages and completely disappearing in the SN stage. These
data, alongside with the expression of key cell cycle regulators,
indicate that the cell cycle is arrested after the P/M stage.
Theantimicrobial activity of neutrophils isachieved throughROS
production by the NADPH oxidase enzyme complex. We showed
that this enzyme complex activity reaches its peak only at the end
of differentiation, although its expression is already detectable at
the MM stage. The observed difference in ROS production during
differentiation between PMA and PAF/fMLP kinetics highlights
that G protein-coupled receptor and its signaling machinery are
required to trigger the process. Indeed, we showed that when
the surface expression of fMLP receptor FPR1 is low, at early
stages of development, the response to PAF/fMLP is impaired.
Along the same line, we noticed that genes encoding for the
proteins contained in the various granules displayed different
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Figure 5. Cell Cycle and NADPH Oxidase Regulation in Neutrophil Differentiation
(A) Flowcytometry analysis of Ki67expression in bonemarrowneutrophil progenitor fractions normalized to isotopecontrol in gray for the threebiological replicates.
(B) Schematic of the assembly of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex on the phagosomal or plasmamembrane
upon neutrophil activation.
(C) Heatmap representing the expression in log2(FPKM+1) of NADPH complex subunits during neutrophil differentiation.
(D) Respiratory burst in sorted neutrophil progenitors from bone marrow and mature PMN upon stimulation with PMA and PAF/fMLP. Results are expressed as
maximal rates in nmol H2O2/min $ 10
6 PMNs and as mean ± SEM from the three biological replicates. t test corrected p values of the consecutive stages are
indicated in the figure: *p < 0.1 and **p < 0.01. ns, nonsignificant. The t test corrected p values of all comparisons are reported in Table S5.
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transcriptional and epigenetic dynamics. Indeed, the proteases
were released by cellular activation only at the mature stage,
because the signaling cascade and surface expression of acti-
vating GPCR receptors were not present at earlier stages.
The results presented in this study shed light on the neutrophil
differentiation processes and represent a useful resource for
future studies on as yet uncharacterized primary immune disor-
ders or neutrophil-related disorders such as congenital neutro-
penia syndromes, Che´diak-Higashi syndrome, and lazy leuko-
cyte syndrome (Dinauer, 2014; Nunoi et al., 1999).
EXPERIMENTAL PROCEDURES
Study Design
Bone marrow neutrophils were collected from three different healthy donors,
and mature neutrophils were collected from other three other different healthy
donors. ChiP-seq, RNA-seq, and WGBS experiments were done on samples
from the same donors.
Cell Isolation and Library Preparation
Thestudywasapprovedby the local ethics committeeofSanquinBloodSupply
Organization and the AcademicMedical Center (Amsterdam, theNetherlands).
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Figure 6. Epigenetics and Transcriptomics
of Granule Proteins
(A) Granule gene expression across differentiation.
Upper and lower boxplot margins indicate first and
third quartiles. LOESS fitting of the data with
relative confidence interval is represented by a
colored line with a shadow area.
(B) Proteolytic activity of the different differentia-
tion stages measured by DQ-BSA cleavage. Triton
X-100 releases total proteolytic activity stored in
the cell by lysis, while proteolytic activity by CytoB/
fMLP is a receptor-mediated release of proteases.
Results are shown as the maximal slopes in RFU/
min and expressed as mean ± SEM from the three
biological replicates. t test corrected p values of
the consecutive stages are indicated in the figure:
*p < 0.1 and **p < 0.01. ns, nonsignificant. The
t test corrected p values of all comparisons are
reported in Table S5.
(C)Representative viewsofepigeneticmodifications
dynamics at five loci encoding for granule proteins.
PMNs were enriched by gradient centrifugation
and purified by negative selection with EasySep
Human Neutrophil Enrichment Kit. Bone marrow
neutrophil progenitors were purified by fluores-
cence-activated cell sorting (FACS) with CD11b
and CD16 (see Supplemental Experimental
Procedures for further details). ChIP-seq and total
RNA-seq libraries were prepared according to
the BLUEPRINT protocols (http://www.blueprint-
epigenome.eu).
ChIP-Seq Analysis and Genome
Segmentation
Sequenced reads were mapped against the
GRCh38 genome assembly with BWA (Li and
Durbin, 2009). ChromHMM software (version
1.10) (Ernst and Kellis, 2012) was then used to
segment the genome in 200 bp intervals and
assign epigenetic states. Chromatin states consistently identified in all three
replicates were represented with a Sankey diagram at each stage of devel-
opment using the ‘‘makeRiver’’ and ‘‘riverplot’’ functions included in the riv-
erplot R package version 0.5.
RNA-Seq Analysis
Trim Galore (version 0.3.7) (http://www.bioinformatics.babraham.ac.uk/
projects/trim_galore/) with parameters ‘‘-q 15 -s 3 –length 30 -e 0.05’’
was used to trim PCR and sequencing adapters. Trimmed reads were
aligned to the Ensembl version 80 (Cunningham et al., 2015) human tran-
scriptome with Bowtie 1.0.1 (Langmead et al., 2009) using the parameters
‘‘-a –best –strata -S -m 100 -X 500 –chunkmbs 256 –nofw –fr.’’ MMSEQ
(version 1.0.8a) (Turro et al., 2014; Turro et al., 2011) was used with default
parameters to quantify gene expression. Genes and transcripts with poste-
rior probability > 0.5 (calculated by MMDiff), absolute fold change > 2, and
FPKM (fragments per kilobase of transcript per million mapped reads) > 1
in at least one of the two compared cell types were considered differentially
expressed. Differentially expressed genes in at least one of the comparisons
P/M-MM, MM-BN, BN-SN, SN-PMN, and P/M-PMN (Figure S1) were
clustered using the ‘‘kmeans’’ (Hartigan and Wong, 1979) clustering
R function. Gene expression FPKMs were log2-transformed, and for
each gene the Z score was calculated. We set the number of centers
to seven according to the results of the gap statistic (Tibshirani et al.,
2001) by using the ‘‘clusGap’’ function of the cluster R package.
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SE Identification
SEs in each sample were predicted by the ROSE algorithm (Whyte et al.,
2013) using H3K27ac as the surrogate mark. Briefly, all H3K27ac peaks
within ±2.0 kb around TSSs were first excluded. The remaining peaks closer
than default distance of 12.5 kb were stitched together and subsequently
ranked by normalized H3K27ac level corrected by input background. Finally,
SEs were separated from typical enhancers on the basis of the inflection point
of H3K27ac signal curve.
Functional Enrichment Analysis
Functional enrichment analysis was done by using FIDEA (D’Andrea et al.,
2013) with default settings.
Promoter/Enhancer/SE Gene Assignment
For each transcript annotated in Ensembl version 80 (Cunninghamet al., 2015),
we defined a promoter as the 2,000 bp (±1,000 bp) around its TSS. All the re-
gions defined as promoter by the genome segmentation analysis and the
H3K27ac dynamic analysis were assigned to the genes of the overlapping pro-
moters. All the regions defined as enhancer by segmentation analysis and the
H3K27ac analysis were assigned to the genewith the closest promoter (distant
less than 10,000 bp) and to genes with promoters overlapping their interacting
regions (CHiCAGO scoreR 5 in neutrophils) derived from the study of Javierre
et al. (2016). The ‘‘findOverlaps’’ and ‘‘distanceToNearest’’ functions of the
GenomicRanges (Lawrence et al., 2013) R package were used to make region
comparisons.
Motif analysis was performed with the HOMER (Heinz et al., 2010) program.
WGBS was carried out to minimum genome coverage of 303 with estab-
lished protocols (Kulis et al., 2012).
Differential methylation was estimated for (1) individual CpG sites in pairwise
comparisons by using methyl_diff (Raineri et al., 2014) and across regions in
group-wise comparison by using replicates with metilene (J€uhling et al., 2016).
Association between Acetylation and Expression Clusters
We built a contingency table with the number of genes for each acetylation
cluster (rows) and gene expression cluster (columns). The Pearson’s chi-
square test was used to verify the non-independence of the two categorical
variables. The significance of the association of each gene expression cluster
with each dynamic acetylation cluster was tested by a hyper-geometric test,
and the derived p values were corrected using the Benjamini-Hochberg
method (Hochberg and Benjamini, 1990).
NADPH-oxidase activity was assessed as the release of hydrogen peroxide
determinedwith anAmplex Red kit (Drewniak et al., 2013; Kuijpers et al., 2005).
Protease release after degranulation was measured with DQ-green BSA
(see Supplemental Experimental Procedures for further details).
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